« Back
Home /
Canakinumab Biosimilar（Anti-IL-1b Reference Antibody）

Canakinumab Biosimilar（Anti-IL-1b Reference Antibody）

Item no.	DCC-A235-100mg
Manufacturer	DCChemicals
CASRN	914613-48-2
Amount	100 mg
Quantity options	100 mg 10 mg 1 mg 5 mg
Category	Neutralization
Applications	NT
Specific against	other
Available
Manufacturer - Applications	Canakinumab (ACZ885) is a recombinant human anti-IL-1β monoclonal antibody. Canakinumab shows IC50 values of 43.6 and 40.8 pM for human and marmoset IL-1β, respectively. The mode of action of canakinumab is based on the neutralization of IL-1β signaling, resulting in suppression of inflammation related to disorders of autoimmune origin.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Delivery expected until 10/16/2025

Express Delivery: Save 3 days

Compare

Add to wishlist

Get an offer